Telmisartan (Micardis) usage and correct dosage

Telmisartan, trade nameMicardis, is an angiotensin II receptor blocker (ARB). By preventing angiotensin II from binding to its receptors, it effectively prevents excessive contraction of blood vessels, thereby lowering blood pressure and improving blood flow. This property makes it an important drug in treatinghigh blood pressure and can significantly reduce the risk of stroke and heart attack. In addition, telmisartan is used to reduce the risk of stroke, heart attack, or death from heart disease in people 55 and older who have risk factors for serious heart disease.

Telmisartan is relatively simple to use and is generally recommended to be taken at the same time every day, with or without food. For patients with high blood pressure, common adult doses are as follows:

For initial treatment, the recommended dose is40 mg orally once daily. Most patients can see a blood pressure-lowering effect within 2 weeks of starting treatment, and the maximum blood pressure-lowering effect is usually apparent within 4 weeks of starting treatment. If the initial dose fails to achieve the desired blood pressure control effect, the dose can be increased to a maximum dose of 80mg, taken orally once a day.

For patients aiming to reduce cardiovascular risk, telmisartan 80 mg taken orally once daily is generally recommended Of note, it is unclear whether doses below 80 mg are effective in reducing cardiovascular morbidity and mortality. In addition, when starting to use telmisartan to reduce cardiovascular risk, patients are advised to monitor their blood pressure closely and adjust the dosage of other antihypertensive drugs if necessary.

In short, telmisartan is a safe and effective antihypertensive drug, and its usage and correct dosage selection must be guided by a doctor based on the patient's specific conditions. Through reasonable dose adjustment and blood pressure monitoring, Telmisartan can help patients effectively control blood pressure and reduce the risk of cardiovascular disease.

Reference materials:https://www.drugs.com/micardis.html